J&J Health for Humanity — ESG Goals Tracker

Lunarix Technologies LLC · Yiduo Xiao · Data: J&J ESG Reports 2019–2023 · CDP · SEC EDGAR

Live dashboard SQL + Python + Tableau Third-party assured data

Reporting year:

Carbon reduction

31%

vs 2019 baseline

↑ +5pp vs prior year

Renewable energy

70%

target: 100% by 2025

↑ +2pp vs prior year

Recyclable packaging

82%

target: 100% by 2025

↑ +4pp vs prior year

Water replenishment

95%

water-stressed regions

↑ +4pp vs prior year

Supplier coverage

93%

EcoVadis assessed

↑ +5pp vs prior year

Carbon emissions trajectory vs. net-zero pathway

Scope 1+2 metric tons CO₂e · 2019–2023 actuals + 2030/2045 targets

Goal progress snapshot

% progress toward 2025 targets · selected year

Pharma industry benchmark · Scope 1+2 emissions & renewable energy · 2023

Company	Scope 1+2 (M mt CO₂e)	Renewable %	Net-zero target
Johnson & Johnson ★	5.20M	70%	2045
Merck	4.80M	80%	2040
Bristol Myers Squibb	3.10M	100%	2040
Pfizer	6.40M	62%	2040